Report Detail

Request for Sample of this report

Pharma & Healthcare Global Pyrazinamide Tablets Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

  • RnM4745953
    • |
  • 28 September, 2026
    • |
  • Global
    • |
  • 142 Pages
    • |
  • GIR
    • |
  • Pharma & Healthcare

According to our (Global Info Research) latest study, the global Pyrazinamide Tablets market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
Pyrazinamide Tablets, indicated to be effective against mycobacterium only, are used in combination with other antituberculosis agents such as streptomycin, isoniazid, rifampicin and ethambutol to treat tuberculosis.
This report is a detailed and comprehensive analysis for global Pyrazinamide Tablets market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Pyrazinamide Tablets market size and forecasts, in consumption value ($ Million), sales quantity (K Boxes), and average selling prices (US$/Box), 2021-2032
Global Pyrazinamide Tablets market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Boxes), and average selling prices (US$/Box), 2021-2032
Global Pyrazinamide Tablets market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Boxes), and average selling prices (US$/Box), 2021-2032
Global Pyrazinamide Tablets market shares of main players, shipments in revenue ($ Million), sales quantity (K Boxes), and ASP (US$/Box), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Pyrazinamide Tablets
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Pyrazinamide Tablets market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Akorn Operating, Healthy Life Pharma, Wellona Pharma, Lupin, Akorn, Cadila Pharmaceuticals, Macleods Pharma, Morningside Healthcare, Datong Liqun Pharmaceutical, Guangdong Taicheng Pharmaceutical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Pyrazinamide Tablets market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
0.5g/Tablet
0.25g/Tablet
Market segment by Application
Hospital
Clinic
Drugstore
Major players covered
Akorn Operating
Healthy Life Pharma
Wellona Pharma
Lupin
Akorn
Cadila Pharmaceuticals
Macleods Pharma
Morningside Healthcare
Datong Liqun Pharmaceutical
Guangdong Taicheng Pharmaceutical
Shenyang Red Flag Pharmaceutical(Fosun Pharmaceutical)
Changchun Maoshun Pharmaceutical
Jiangsu Sihuan Bioengineering Pharmaceutical
Chongqing Huapont Pharmaceutical
Suzhou Homesun Pharmaceutical
Chengdu Jinhua Pharmaceutical
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Pyrazinamide Tablets product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Pyrazinamide Tablets, with price, sales quantity, revenue, and global market share of Pyrazinamide Tablets from 2021 to 2026.
Chapter 3, the Pyrazinamide Tablets competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Pyrazinamide Tablets breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Pyrazinamide Tablets market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Pyrazinamide Tablets.
Chapter 14 and 15, to describe Pyrazinamide Tablets sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Pyrazinamide Tablets Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 0.5g/Tablet
    • 1.3.3 0.25g/Tablet
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Pyrazinamide Tablets Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Hospital
    • 1.4.3 Clinic
    • 1.4.4 Drugstore
  • 1.5 Global Pyrazinamide Tablets Market Size & Forecast
    • 1.5.1 Global Pyrazinamide Tablets Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global Pyrazinamide Tablets Sales Quantity (2021-2032)
    • 1.5.3 Global Pyrazinamide Tablets Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 Akorn Operating
    • 2.1.1 Akorn Operating Details
    • 2.1.2 Akorn Operating Major Business
    • 2.1.3 Akorn Operating Pyrazinamide Tablets Product and Services
    • 2.1.4 Akorn Operating Pyrazinamide Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Akorn Operating Recent Developments/Updates
  • 2.2 Healthy Life Pharma
    • 2.2.1 Healthy Life Pharma Details
    • 2.2.2 Healthy Life Pharma Major Business
    • 2.2.3 Healthy Life Pharma Pyrazinamide Tablets Product and Services
    • 2.2.4 Healthy Life Pharma Pyrazinamide Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Healthy Life Pharma Recent Developments/Updates
  • 2.3 Wellona Pharma
    • 2.3.1 Wellona Pharma Details
    • 2.3.2 Wellona Pharma Major Business
    • 2.3.3 Wellona Pharma Pyrazinamide Tablets Product and Services
    • 2.3.4 Wellona Pharma Pyrazinamide Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Wellona Pharma Recent Developments/Updates
  • 2.4 Lupin
    • 2.4.1 Lupin Details
    • 2.4.2 Lupin Major Business
    • 2.4.3 Lupin Pyrazinamide Tablets Product and Services
    • 2.4.4 Lupin Pyrazinamide Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Lupin Recent Developments/Updates
  • 2.5 Akorn
    • 2.5.1 Akorn Details
    • 2.5.2 Akorn Major Business
    • 2.5.3 Akorn Pyrazinamide Tablets Product and Services
    • 2.5.4 Akorn Pyrazinamide Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Akorn Recent Developments/Updates
  • 2.6 Cadila Pharmaceuticals
    • 2.6.1 Cadila Pharmaceuticals Details
    • 2.6.2 Cadila Pharmaceuticals Major Business
    • 2.6.3 Cadila Pharmaceuticals Pyrazinamide Tablets Product and Services
    • 2.6.4 Cadila Pharmaceuticals Pyrazinamide Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Cadila Pharmaceuticals Recent Developments/Updates
  • 2.7 Macleods Pharma
    • 2.7.1 Macleods Pharma Details
    • 2.7.2 Macleods Pharma Major Business
    • 2.7.3 Macleods Pharma Pyrazinamide Tablets Product and Services
    • 2.7.4 Macleods Pharma Pyrazinamide Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Macleods Pharma Recent Developments/Updates
  • 2.8 Morningside Healthcare
    • 2.8.1 Morningside Healthcare Details
    • 2.8.2 Morningside Healthcare Major Business
    • 2.8.3 Morningside Healthcare Pyrazinamide Tablets Product and Services
    • 2.8.4 Morningside Healthcare Pyrazinamide Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Morningside Healthcare Recent Developments/Updates
  • 2.9 Datong Liqun Pharmaceutical
    • 2.9.1 Datong Liqun Pharmaceutical Details
    • 2.9.2 Datong Liqun Pharmaceutical Major Business
    • 2.9.3 Datong Liqun Pharmaceutical Pyrazinamide Tablets Product and Services
    • 2.9.4 Datong Liqun Pharmaceutical Pyrazinamide Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Datong Liqun Pharmaceutical Recent Developments/Updates
  • 2.10 Guangdong Taicheng Pharmaceutical
    • 2.10.1 Guangdong Taicheng Pharmaceutical Details
    • 2.10.2 Guangdong Taicheng Pharmaceutical Major Business
    • 2.10.3 Guangdong Taicheng Pharmaceutical Pyrazinamide Tablets Product and Services
    • 2.10.4 Guangdong Taicheng Pharmaceutical Pyrazinamide Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Guangdong Taicheng Pharmaceutical Recent Developments/Updates
  • 2.11 Shenyang Red Flag Pharmaceutical(Fosun Pharmaceutical)
    • 2.11.1 Shenyang Red Flag Pharmaceutical(Fosun Pharmaceutical) Details
    • 2.11.2 Shenyang Red Flag Pharmaceutical(Fosun Pharmaceutical) Major Business
    • 2.11.3 Shenyang Red Flag Pharmaceutical(Fosun Pharmaceutical) Pyrazinamide Tablets Product and Services
    • 2.11.4 Shenyang Red Flag Pharmaceutical(Fosun Pharmaceutical) Pyrazinamide Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 Shenyang Red Flag Pharmaceutical(Fosun Pharmaceutical) Recent Developments/Updates
  • 2.12 Changchun Maoshun Pharmaceutical
    • 2.12.1 Changchun Maoshun Pharmaceutical Details
    • 2.12.2 Changchun Maoshun Pharmaceutical Major Business
    • 2.12.3 Changchun Maoshun Pharmaceutical Pyrazinamide Tablets Product and Services
    • 2.12.4 Changchun Maoshun Pharmaceutical Pyrazinamide Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 Changchun Maoshun Pharmaceutical Recent Developments/Updates
  • 2.13 Jiangsu Sihuan Bioengineering Pharmaceutical
    • 2.13.1 Jiangsu Sihuan Bioengineering Pharmaceutical Details
    • 2.13.2 Jiangsu Sihuan Bioengineering Pharmaceutical Major Business
    • 2.13.3 Jiangsu Sihuan Bioengineering Pharmaceutical Pyrazinamide Tablets Product and Services
    • 2.13.4 Jiangsu Sihuan Bioengineering Pharmaceutical Pyrazinamide Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.13.5 Jiangsu Sihuan Bioengineering Pharmaceutical Recent Developments/Updates
  • 2.14 Chongqing Huapont Pharmaceutical
    • 2.14.1 Chongqing Huapont Pharmaceutical Details
    • 2.14.2 Chongqing Huapont Pharmaceutical Major Business
    • 2.14.3 Chongqing Huapont Pharmaceutical Pyrazinamide Tablets Product and Services
    • 2.14.4 Chongqing Huapont Pharmaceutical Pyrazinamide Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.14.5 Chongqing Huapont Pharmaceutical Recent Developments/Updates
  • 2.15 Suzhou Homesun Pharmaceutical
    • 2.15.1 Suzhou Homesun Pharmaceutical Details
    • 2.15.2 Suzhou Homesun Pharmaceutical Major Business
    • 2.15.3 Suzhou Homesun Pharmaceutical Pyrazinamide Tablets Product and Services
    • 2.15.4 Suzhou Homesun Pharmaceutical Pyrazinamide Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.15.5 Suzhou Homesun Pharmaceutical Recent Developments/Updates
  • 2.16 Chengdu Jinhua Pharmaceutical
    • 2.16.1 Chengdu Jinhua Pharmaceutical Details
    • 2.16.2 Chengdu Jinhua Pharmaceutical Major Business
    • 2.16.3 Chengdu Jinhua Pharmaceutical Pyrazinamide Tablets Product and Services
    • 2.16.4 Chengdu Jinhua Pharmaceutical Pyrazinamide Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.16.5 Chengdu Jinhua Pharmaceutical Recent Developments/Updates

3 Competitive Environment: Pyrazinamide Tablets by Manufacturer

  • 3.1 Global Pyrazinamide Tablets Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Pyrazinamide Tablets Revenue by Manufacturer (2021-2026)
  • 3.3 Global Pyrazinamide Tablets Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Pyrazinamide Tablets by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Pyrazinamide Tablets Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Pyrazinamide Tablets Manufacturer Market Share in 2025
  • 3.5 Pyrazinamide Tablets Market: Overall Company Footprint Analysis
    • 3.5.1 Pyrazinamide Tablets Market: Region Footprint
    • 3.5.2 Pyrazinamide Tablets Market: Company Product Type Footprint
    • 3.5.3 Pyrazinamide Tablets Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Pyrazinamide Tablets Market Size by Region
    • 4.1.1 Global Pyrazinamide Tablets Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Pyrazinamide Tablets Consumption Value by Region (2021-2032)
    • 4.1.3 Global Pyrazinamide Tablets Average Price by Region (2021-2032)
  • 4.2 North America Pyrazinamide Tablets Consumption Value (2021-2032)
  • 4.3 Europe Pyrazinamide Tablets Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Pyrazinamide Tablets Consumption Value (2021-2032)
  • 4.5 South America Pyrazinamide Tablets Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Pyrazinamide Tablets Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Pyrazinamide Tablets Sales Quantity by Type (2021-2032)
  • 5.2 Global Pyrazinamide Tablets Consumption Value by Type (2021-2032)
  • 5.3 Global Pyrazinamide Tablets Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Pyrazinamide Tablets Sales Quantity by Application (2021-2032)
  • 6.2 Global Pyrazinamide Tablets Consumption Value by Application (2021-2032)
  • 6.3 Global Pyrazinamide Tablets Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Pyrazinamide Tablets Sales Quantity by Type (2021-2032)
  • 7.2 North America Pyrazinamide Tablets Sales Quantity by Application (2021-2032)
  • 7.3 North America Pyrazinamide Tablets Market Size by Country
    • 7.3.1 North America Pyrazinamide Tablets Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Pyrazinamide Tablets Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Pyrazinamide Tablets Sales Quantity by Type (2021-2032)
  • 8.2 Europe Pyrazinamide Tablets Sales Quantity by Application (2021-2032)
  • 8.3 Europe Pyrazinamide Tablets Market Size by Country
    • 8.3.1 Europe Pyrazinamide Tablets Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Pyrazinamide Tablets Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Pyrazinamide Tablets Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Pyrazinamide Tablets Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Pyrazinamide Tablets Market Size by Region
    • 9.3.1 Asia-Pacific Pyrazinamide Tablets Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Pyrazinamide Tablets Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Pyrazinamide Tablets Sales Quantity by Type (2021-2032)
  • 10.2 South America Pyrazinamide Tablets Sales Quantity by Application (2021-2032)
  • 10.3 South America Pyrazinamide Tablets Market Size by Country
    • 10.3.1 South America Pyrazinamide Tablets Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Pyrazinamide Tablets Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Pyrazinamide Tablets Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Pyrazinamide Tablets Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Pyrazinamide Tablets Market Size by Country
    • 11.3.1 Middle East & Africa Pyrazinamide Tablets Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Pyrazinamide Tablets Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Pyrazinamide Tablets Market Drivers
  • 12.2 Pyrazinamide Tablets Market Restraints
  • 12.3 Pyrazinamide Tablets Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Pyrazinamide Tablets and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Pyrazinamide Tablets
  • 13.3 Pyrazinamide Tablets Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Pyrazinamide Tablets Typical Distributors
  • 14.3 Pyrazinamide Tablets Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Pyrazinamide Tablets. Industry analysis & Market Report on Pyrazinamide Tablets is a syndicated market report, published as Global Pyrazinamide Tablets Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Pyrazinamide Tablets market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,690.04
    		4,035.06
    		5,380.08
    		3,239.88
    		4,859.82
    		6,479.76
    		531,361.20
    		797,041.80
    		1,062,722.40
    		293,712.00
    		440,568.00
    		587,424.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo